Jay Matushak's most recent trade in NeueHealth Inc. was a trade of 472 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on May 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 12 May 2025 | 472 | 40,556 | - | 6.8 | 3,191 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 978 | 41,028 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2025 | 978 | 0 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 13 Mar 2025 | 4,448 | 41,592 | - | 6.7 | 29,980 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 13 Mar 2025 | 1,542 | 40,050 | - | 6.1 | 9,452 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 24,000 | 48,000 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2025 | 24,000 | 47,673 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.93 per share. | 11 Mar 2025 | 1,633 | 46,040 | - | 6.9 | 11,317 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.85 per share. | 11 Mar 2025 | 814 | 23,673 | - | 6.9 | 5,576 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,444 | 0 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,444 | 24,671 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.19 per share. | 07 Mar 2025 | 1,860 | 22,227 | - | 7.2 | 13,373 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 07 Mar 2025 | 184 | 24,487 | - | 7.1 | 1,299 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 6,340 | 24,087 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 6,340 | 6,340 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.33 per share. | 06 Jan 2025 | 4,970 | 17,747 | - | 7.3 | 36,430 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 13,237 | 0 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2025 | 13,237 | 22,717 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 263 | 9,567 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 263 | 0 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.18 per share. | 04 Oct 2024 | 87 | 9,480 | - | 5.2 | 451 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 978 | 978 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 978 | 9,621 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.05 per share. | 09 May 2024 | 317 | 9,304 | - | 6.1 | 1,918 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 180,000 | 180,000 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 72,000 | 72,000 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.27 per share. | 18 Mar 2024 | 1,083 | 8,643 | - | 7.3 | 7,873 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.10 per share. | 14 Mar 2024 | 248 | 9,726 | - | 7.1 | 1,761 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.06 per share. | 14 Mar 2024 | 173 | 9,974 | - | 7.1 | 1,221 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.30 per share. | 11 Mar 2024 | 251 | 10,147 | - | 7.3 | 1,832 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.11 per share. | 11 Mar 2024 | 193 | 10,514 | - | 8.1 | 1,565 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 11 Mar 2024 | 116 | 10,398 | - | 7.8 | 900 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,444 | 11,646 | - | - | Common Stock | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,444 | 2,444 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.88 per share. | 07 Mar 2024 | 570 | 11,076 | - | 9.9 | 5,632 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.42 per share. | 07 Mar 2024 | 369 | 10,707 | - | 8.4 | 3,107 | Common Stock |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 6,341 | 12,680 | - | - | Restricted Stock Units | |
| NeueHealth Inc. | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 6,341 | 9,202 | - | - | Common Stock | |
| Bright Health Group Inc | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2023 | 264 | 263 | - | - | Restricted Stock Units | |
| Bright Health Group Inc | Jay Matushak | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2023 | 264 | 2,948 | - | - | Common Stock | |
| Bright Health Group Inc | Jay Matushak | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.71 per share. | 04 Oct 2023 | 87 | 2,861 | - | 5.7 | 497 | Common Stock |